BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25378634)

  • 1. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
    Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
    Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor.
    Lee YE; Choi SA; Kwack PA; Kim HJ; Kim IH; Wang KC; Phi JH; Lee JY; Chong S; Park SH; Park KD; Hwang DW; Joo KM; Kim SK
    Neuro Oncol; 2017 Aug; 19(8):1079-1087. PubMed ID: 28340172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram potentiates the anticancer effect of cisplatin in atypical teratoid/rhabdoid tumors (AT/RT).
    Jangra A; Choi SA; Yang J; Koh EJ; Phi JH; Lee JY; Wang KC; Kim SK
    Cancer Lett; 2020 Aug; 486():38-45. PubMed ID: 32428661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of disulfiram and H
    Read E; Milford J; Zhu J; Wu L; Bilodeau M; Yang G
    Toxicol Appl Pharmacol; 2021 Sep; 426():115642. PubMed ID: 34242567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
    Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase.
    Choi SA; Lee JY; Phi JH; Wang KC; Park CK; Park SH; Kim SK
    Eur J Cancer; 2014 Jan; 50(1):137-49. PubMed ID: 24103144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
    Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion channels in pediatric CNS Atypical Teratoid/Rhabdoid Tumor (AT/RT) cells: potential targets for novel therapeutic agents.
    Banderali U; Jayanthan A; Hoeksema KA; Narendran A; Giles WR
    J Neurooncol; 2012 Mar; 107(1):111-9. PubMed ID: 21971736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
    Yao W; Qian X; Ochsenreither S; Soldano F; DeLeo AB; Sudhoff H; Oppel F; Kuppig A; Klinghammer K; Kaufmann AM; Albers AE
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target.
    Weingart MF; Roth JJ; Hutt-Cabezas M; Busse TM; Kaur H; Price A; Maynard R; Rubens J; Taylor I; Mao XG; Xu J; Kuwahara Y; Allen SJ; Erdreich-Epstein A; Weissman BE; Orr BA; Eberhart CG; Biegel JA; Raabe EH
    Oncotarget; 2015 Feb; 6(5):3165-77. PubMed ID: 25638158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thiocarbamate disulphide drug, disulfiram induces osteopenia in rats by inhibition of osteoblast function due to suppression of acetaldehyde dehydrogenase activity.
    Mittal M; Khan K; Pal S; Porwal K; China SP; Barbhuyan TK; Baghel KS; Rawat T; Sanyal S; Bhadauria S; Sharma VL; Chattopadhyay N
    Toxicol Sci; 2014 May; 139(1):257-70. PubMed ID: 24496638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
    Skrott Z; Majera D; Gursky J; Buchtova T; Hajduch M; Mistrik M; Bartek J
    Oncogene; 2019 Oct; 38(40):6711-6722. PubMed ID: 31391554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.
    Lun X; Wells JC; Grinshtein N; King JC; Hao X; Dang NH; Wang X; Aman A; Uehling D; Datti A; Wrana JL; Easaw JC; Luchman A; Weiss S; Cairncross JG; Kaplan DR; Robbins SM; Senger DL
    Clin Cancer Res; 2016 Aug; 22(15):3860-75. PubMed ID: 27006494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors.
    Wang NN; Wang LH; Li Y; Fu SY; Xue X; Jia LN; Yuan XZ; Wang YT; Tang X; Yang JY; Wu CF
    Exp Cell Res; 2018 Jan; 362(1):72-82. PubMed ID: 29155365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
    Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
    Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
    Choi SA; Lee JY; Kwon SE; Wang KC; Phi JH; Choi JW; Jin X; Lim JY; Kim H; Kim SK
    PLoS One; 2015; 10(6):e0129292. PubMed ID: 26076490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC.
    Wu L; Meng F; Dong L; Block CJ; Mitchell AV; Wu J; Jang H; Chen W; Polin L; Yang Q; Dou QP; Wu G
    Sci Rep; 2019 Jan; 9(1):236. PubMed ID: 30659204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.